Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Smokey1958on Dec 03, 2020 3:16pm
193 Views
Post# 32030327

Share Price

Share PriceOutside of using it as an indicator to average down, the share price should not be the measure of the value of this stock ....in this moment. Prior to covid, longs would have been ecstatic to see its value above $.06. A year ago it would sometimes fall to $.01. Nothing will change the sp until there is news or certain warrants are exercised, NOTHING. Speculation alone won't alter the reality that the best "medicine" for shareholders is news. As per their NR, news is unlikely to be forthcoming until the end of this month, at the earliest. I'm quite sure that if and when CoviSafe makes it to FDA and/or HC approval EVERYONE is going to hear about it. Until then a filings release within the next two weeks might reveal a little more. Even that only takes us to October 31, 2020 .....right before the November 4, 2020 NR bombshell concerning Torion Biosciences.

glta
<< Previous
Bullboard Posts
Next >>